Status:
COMPLETED
Smartphone App for Cancer Medication Adherence
Lead Sponsor:
Columbia University
Conditions:
Carcinoma
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
For this current proposal, the investigator will conduct a single-center prospective non-randomized pilot interventional study in patients with any stage and type of cancer who are either taking at le...
Detailed Description
Many patients with cancer experience frustration with the large number and complex scheduling of their medications. This study will help find out how much "pill burden" exists in patients with cancer,...
Eligibility Criteria
Inclusion
- Any type/stage cancer
- Patients must be taking either:
- at least one oral anti-cancer drug (OACD) or
- at least one oral medication (non-OACD) for management of a chronic condition in addition to receiving non-oral cancer treatment
- Patients must have access to a mobile phone or tablet that can download the Medisafe App. (ie apple/android)
- Subjects must be able to complete self-administered questionnaires in English or Spanish.
- Co-enrollment in trials involving pharmacologic therapy is allowed.
Exclusion
- Inability to provide informed consent
Key Trial Info
Start Date :
January 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05225090
Start Date
January 15 2020
End Date
May 31 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Irving Medical Center
New York, New York, United States, 10032